Trial
NCT01765270
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
Saxagliptin
Why stopped
The study was stopped due to poor enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-29